JD Health International Inc.
6618
Κατάταξη σε μετοχές
#1400
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Τιμή μετοχής
$4.96
Κεφαλαιοποίηση
$15.82B
Αλλαγή (1 ημέρα)
-2.58%
Αλλαγή (1 έτος)
-40.00%
Χώρα
CN
Εμπόριο JD Health International Inc. (6618)
Κατηγορία
Healthcare
Κέρδη για την JD Health International Inc. (6618)
Κέρδη τον Jun 2026 TTM: $1.07B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της JD Health International Inc., τα τρέχοντα κέρδη της εταιρείας είναι $1.07B. Το 2023, η εταιρεία παρουσίασε κέρδη $380.49M, αύξηση σε σχέση με των κερδών του 2022 που ήταν $100.87M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την JD Health International Inc. από 2017 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $1.07B | 62.26% |
| 2024 | $657.16M | 72.71% |
| 2023 | $380.49M | 277.20% |
| 2022 | $100.87M | -171.12% |
| 2021 | $-141.84M | -94.57% |
| 2020 | $-2.61B | 2,080.12% |
| 2019 | $-119.87M | -369.26% |
| 2018 | $44.52M | 13.15% |
| 2017 | $39.34M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $9.87B | 825.69% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 262.46% |
US
|
|
| $687.82M | -35.50% |
SA
|
|
| $1.25B | 16.92% |
BR
|
